Page last updated: 2024-11-03

risperidone and Hyperparathyroidism, Primary

risperidone has been researched along with Hyperparathyroidism, Primary in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Otsuki, K1
Izuhara, M1
Miura, S1
Yamashita, S1
Nagahama, M1
Hayashida, M1
Hashioka, S1
Miyaoka, T1
Hotta, Y1
Shimizu, Y1
Inagaki, M1

Other Studies

1 other study available for risperidone and Hyperparathyroidism, Primary

ArticleYear
Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report.
    Medicine, 2021, Mar-26, Volume: 100, Issue:12

    Topics: Aged; Antipsychotic Agents; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid

2021